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This work sought to define how pancreatitis affected antibiotic distribution in a perfused rat pancreas model.
The distribution kinetics of four antibiotics were examined in control animals and animals with pancreatitis.
Meropenem and piperacillin distributed into the extracellular space, and their distribution kinetics were
unaffected by pancreatitis. In contrast, in pancreatic cells from animals with pancreatitis, ciprofloxacin showed
a reduced uptake and clindamycin showed a reduced distribution.
Although the use of antibiotics in treating pancreatitis still
remains controversial (3, 4, 15), bacterial infection is the lead-
ing cause of morbidity and mortality in patients with severe
acute pancreatitis (SAP) (14). Studies have investigated pen-
etration into diseased human tissue (1, 2, 5, 13), as well as a
variety of animal models (6, 9, 10, 16).
However, there appear to be few studies examining the rate
of antibiotic uptake into pancreatic tissue. To our knowledge,
this is one of the few studies investigating the rate of uptake of
antibiotics in normal and diseased pancreas and most likely the
first in the isolated perfused pancreas. Such a model enables
the precise rate of uptake and efflux for antibiotics in the
pancreas to be defined, as well as the nature of their distribu-
tion in the normal and diseased pancreas.
All procedures involving animals were carried out with ad-
herence to the University of Queensland Animal Care Com-
mittee guidelines (Animal Ethics Committee [AEC] project
PAH/588/06/NHMRC). Pancreatitis was induced by giving
male Wistar rats a single injection of 6 mg of dibutyltin dichlo-
ride (DBTC) per kg of body weight, via the tail vein, according
to a previously described method (16). Rats were not allowed
to eat from 104 h postinjection, and following the final blood
sample at 120 h postinjection, they were anesthetized as pre-
viously described (8). The pancreas perfusions were carried out
similarly to the method described previously (8) with a series of
5 individual 20-l bolus injections (7): piperacillin (2 mg/ml),
meropenem (1 mg/ml), ciprofloxacin (200 g/ml), clindamycin
(1 mg/ml), and [14C]sucrose with 3H-labeled water (each drug
bolus contained 125I-labeled albumin). The perfusate and out-
flow profiles were analyzed as described previously to obtain
the unbound fraction in perfusate (fu), volume of distribution
of albumin or albumin space (Valb), volume of distribution of
sucrose or sucrose space (Vsuc), volume of distribution of water
or water space (Vwater), drug distribution volume (V), fraction
unbound in tissues (fuT), permeation rate constant kin (perme-
ability rate constant from the vascular space to the extravas-
cular space), efflux rate constant kout (permeability rate con-
stant from the extravascular space to the vascular space), and
permeability surface area product (PS) (7, 8). Fibrosis was
quantified using a method that has been previously utilized for
the liver (11).
Histological examination of the diseased pancreas showed
pathologies, including the formation of ductal complexes with
apoptotic and necrotic cells, massive inflammatory cell infiltra-
tion, fat necrosis, and leukocyte infiltration. The DBTC-
treated animals had significantly increased fibrosis indexes
(17.6% 1.7% for animals with pancreatitis and 0.5% 0.2%
for control animals; P  0.002), characterized by extensive
collagen deposition. The dry/wet ratio of the pancreas prepa-
ration was unchanged in the diseased animals.
Similar albumin and sucrose spaces were seen for the control
and pancreatitis models, but there was a significantly lower
water space in animals with pancreatitis (P  0.02) (Table 1).
Thus, there was no difference in interstitial volume (0.15 
0.02 ml  g1 for control animals and 0.16  0.03 ml  g1 for
animals with pancreatitis), but there was a significantly lower
cellular volume in the diseased pancreas (0.42  0.02 ml  g1
for control animals and 0.29  0.03 ml  g1 for animals with
pancreatitis; P  0.02).
Figure 1 shows the outflow concentration-time profiles for
the antibiotics in the perfused rat pancreas. Also included in
Fig. 1 are the nonlinear regression fits of the physiologically
based pharmacokinetic model used. The kinetic parameter
estimates derived from these profiles are shown in Table 2. It
is evident that piperacillin and meropenem are mainly distrib-
uted into the sucrose space (i.e., perfusate plus interstitial). In
addition, their disposition kinetics appear to be unaffected by
the presence of pancreatitis. It is evident that the uptake of
ciprofloxacin (as defined by PS, kin, and kin/kout) into the pan-
creas is inhibited by pancreatitis but that its efflux is relatively
unaffected. In contrast, the influx and efflux constants for clin-
damycin are unaffected by pancreatitis. In addition, the binding
of clindamycin in pancreas tissue (fuT) was unchanged (0.19 
0.03 for control animals and 0.26  0.04 for animals with
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pancreatitis). Hence, as the extracellular (sucrose) space is
unchanged, the decrease in V for clindamycin arises mainly
from a decrease in the cellular space it distributes into in the
pancreas (V  Valb  fu  Vcellular/fuT) (8). This finding is
consistent with the change in cellular volume based on the
difference in the water and sucrose spaces as described above.
This work suggests that antibiotics with a distribution limited
to the pancreas interstitial space are not significantly affected
by pancreatitis, consistent with the similar extracellular spaces
estimated using sucrose (Table 1). The result for piperacillin
agrees with the finding of no change in penetration into dis-
eased tissue as reported previously (19). However, the current
result for meropenem is in conflict with the work of Saglam-
kaya et al. (17). They investigated animals both 6 h (disease
characterized by edema) and 48 h (more necrotic tissue) fol-
lowing treatment with combined glycodexoxycholic acid infu-
sion and intravenous cereulein to induce SAP. Meropenem’s
penetration was highest at 6 h (Cpancreas/Cserum  0.93, where
Cpancreas is the concentration of drug in pancreas and Cserum is
the concentration of drug in serum) and fell slightly, yet it was
still significantly higher than the control at 48 h (Cpancreas/
Cserum  0.81 versus Cpancreas/Cserum  0.33 for the control).
Perhaps this penetration would continue to decrease with time
as the diseased tissue becomes less edematous. Several studies
have shown that penetration differences (both increased and
decreased) into diseased versus control tissue are more
marked in the earlier and/or more edematous forms of acute
pancreatitis (9, 10, 17), with evidence suggesting that this is
TABLE 1. Volumes of distribution of albumin, sucrose, and water
in the perfused rat pancreas
Parametera
Value (mean  SEM) for parameter in:
Control animals
(n  5)
Diseased animals
(n  6)
Valb (ml  g
1) 0.15  0.01 0.15 0.02
Vsuc (ml  g
1) 0.30  0.03 0.31 0.02
Vwater (ml  g
1) 0.72  0.03 0.60 0.01b
a Abbreviations: Valb, volume of distribution of albumin or albumin space;
Vsuc, volume of distribution of sucrose or sucrose space; Vwater, volume of
distribution of water or water space.
b This value was significantly lower (P  0.02) than the value for control
animals.
FIG. 1. Typical fit of outflow profile data of antibiotics in control and diseased animals. (A to D) Outflow profile data of piperacillin (A),
meropenem (B), ciprofloxacin (C), and clindamycin (D) in control (F) and diseased (E) animals. The lines indicate the fitted curves applying a
physiologically based pharmacokinetic model.
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related to capillary pancreatic blood flow (9). The presence of
more severe necrosis in Saglamkaya’s work than in the present
model may also have contributed to the higher penetration
ratio at the 48-h time point.
The significantly decreased uptake for ciprofloxacin in pan-
creatitis may reflect a potential active uptake of this compound
into the pancreas and an inhibition of the uptake in pancre-
atitis due to fibrosis. There are a number of studies demon-
strating active uptake of ciprofloxacin across epithelial cells
(see, for example, reference 21); however, there do not appear
to be any studies previously suggesting active uptake for cip-
rofloxacin in the pancreas. The almost 10-fold-higher kin/kout
for this drug that has low albumin binding (fu of 0.9) but a
relatively low V suggests that there is an active uptake process.
An inverse relationship between log PS and fibrosis index for
ciprofloxacin (r2  0.68) was seen in the present study, which
further suggests active transport, as we have shown that fibrosis
can reduce PS for cationic drugs and taurocholate extraction in
liver diseases (11, 12). The reduced V for clindamycin attrib-
uted to a reduced cellular volume is consistent with chronic
pancreatitis being associated with a reduced pancreatic volume
(18). A previous study in dogs also observed no significant
change in the pancreas/plasma concentrations of clindamycin
in SAP (20).
In conclusion, the tissue kinetics of meropenem, piperacillin,
ciprofloxacin, and clindamycin have been described in the per-
fused rat pancreas of both control animals and animals with
pancreatitis. The dispositions of meropenem and piperacillin
appear relatively unaffected by pancreatitis, whereas the up-
take of ciprofloxacin is inhibited and there is a reduced distri-
bution of clindamycin into pancreatic cells from animals with
pancreatitis, consistent with an observed reduction in cellular
volume in the pancreas of an animal with pancreatitis.
This work was financially supported by a grant from the National
Health and Medical Research Council of Australia and a University of
Queensland Development grant.
We thank the following people for their valuable assistance: Megan
Bathurst and Tracy Millard (animal handling), Alexander Klentzos
and Yuhong Zou (perfusions), Ben Winkle (high-performance liquid
chromatography), and Clay Winterford, Glenda Gobe, and Leila
Cuttle (histology).
REFERENCES
1. Adam, U., et al. 2001. The penetration of ciprofloxacin into human pancre-
atic and peripancreatic necroses in acute necrotizing pancreatitis. Infection
29:326–331.
2. Bassi, C., et al. 1994. Behavior of antibiotics during human necrotizing
pancreatitis. Antimicrob. Agents Chemother. 38:830–836.
3. Beger, H. G., et al. 2005. Antibiotic prophylaxis in severe acute pancreatitis.
Pancreatology 5:10–19.
4. Besselink, M. G. H., H. C. van Santvoort, B. J. Witteman, and H. G.
Gooszen. 2007. Management of severe acute pancreatitis: it’s all about tim-
ing. Curr. Opin. Crit. Care 13:200–206.
5. Buchler, M., et al. 1992. Human pancreatic tissue concentration of bacteri-
cidal antibiotics. Gastroenterology 103:1902–1908.
6. Drewelow, B., et al. 1992. Antibiotic penetration in necrotizing pancreatitis.
Int. J. Exp. Clin. Chemother. 5:141–148.
7. Fanning, K. J., Y. G. Anissiomv, and M. S. Roberts. 2009. Sulphonylurea
physicochemical-pharmacokinetic relationships in the pancreas and liver.
J. Pharm. Sci. 98:2807–2821.
8. Fanning, K. J., and M. S. Roberts. 2007. Characterization of the physiolog-
ical spaces and distribution of tolbutamide in the perfused rat pancreas.
Pharm. Res. 24:512–520.
9. Foitzik, T., H. G. Hotz, M. Kinzig, F. Sorgel, and H. J. Buhr. 1997. Influence
of changes in pancreatic tissue morphology and capillary blood flow on
antibiotic tissue concentrations in the pancreas during the progression of
acute pancreatitis. Gut 40:526–530.
T
A
B
L
E
2.
K
in
et
ic
pa
ra
m
et
er
s
de
ri
ve
d
fr
om
th
e
ph
ar
m
ac
ok
in
et
ic
m
od
el
us
ed
an
d
pr
ot
ei
n
bi
nd
in
g
of
va
ri
ou
s
an
tib
io
tic
s
in
th
e
pe
rf
us
ed
ra
t
pa
nc
re
as
a
D
ru
g
M
W
L
og P 7
.4
fu
C
on
tr
ol
an
im
al
s
(n

5)
D
is
ea
se
d
an
im
al
s
(n

5)
V
(m
l
g
1
)
k i
n
(s

1
)
k o
u
t
(s

1
)
k i
n
/k
o
u
t
P
S
(m
l
m
in

1

g
1
)
V
(m
l
g
1
)
k i
n
(s

1
)
k o
u
t
(s

1
)
k i
n
/k
o
u
t
P
S
(m
l
m
in

1

g
1
)
Pi
pe
ra
ci
lli
n
51
8

1.
84
0.
85

0.
02
0.
33

0.
04
0.
22

0.
06
0.
13

0.
05
1.
90

0.
40
2.
74

0.
83
0.
27

0.
05
0.
11

0.
01
0.
05

0.
01
2.
80

0.
88
1.
02

0.
06
M
er
op
en
em
38
3

5.
7
0.
75

0.
05
0.
23

0.
02
0.
15

0.
06
0.
12

0.
06
1.
45

0.
22
1.
88

0.
84
0.
20

0.
02
0.
07

0.
01
0.
06

0.
03
1.
26

0.
32
0.
90

0.
12
C
ip
ro
flo
xa
ci
n
33
1

0.
90
0.
90

0.
02
0.
41

0.
05
0.
12

0.
02
0.
01
5

0.
00
4
6.
45

0.
98
1.
35

0.
35
0.
29

0.
03
b
0.
06

0.
01
c
0.
02

0.
02
2.
85

0.
44
b
0.
57

0.
10
b
C
lin
da
m
yc
in
42
5
0.
40
0.
51

0.
01
1.
26

0.
15
0.
16

0.
01
0.
01
1

0.
00
2
15
.5
4

3.
05
3.
01

0.
28
0.
72

0.
12
b
0.
16

0.
03
0.
01

0.
00
1
15
.1
7

2.
98
2.
59

0.
43
a
A
bb
re
vi
at
io
ns
:M
W
,m
ol
ec
ul
ar
w
ei
gh
t;
lo
g
P
7
.4
,l
og
ar
ith
m
of
oc
ta
no
l-w
at
er
pa
rt
iti
on
co
ef
fic
ie
nt
at
pH
7.
4;
fu
,f
ra
ct
io
n
un
bo
un
d
in
pe
rf
us
at
e;
V
,v
ol
um
e
of
di
st
ri
bu
tio
n;
k i
n
,p
er
m
ea
bi
lit
y
ra
te
co
ns
ta
nt
fr
om
th
e
va
sc
ul
ar
sp
ac
e
to
th
e
ex
tr
av
as
cu
la
r
sp
ac
e,
a
pe
rm
ea
tio
n
ra
te
co
ns
ta
nt
;k
o
u
t,
pe
rm
ea
bi
lit
y
ra
te
co
ns
ta
nt
fr
om
th
e
ex
tr
av
as
cu
la
r
sp
ac
e
to
th
e
va
sc
ul
ar
sp
ac
e,
an
ef
flu
x
ra
te
co
ns
ta
nt
;P
S,
pe
rm
ea
bi
lit
y
su
rf
ac
e
ar
ea
pr
od
uc
t.
T
he
m
ea
n

st
an
da
rd
er
ro
r
of
th
e
m
ea
n
is
sh
ow
n
fo
r
ea
ch
pa
ra
m
et
er
.
b
T
hi
s
va
lu
e
w
as
si
gn
ifi
ca
nt
ly
lo
w
er
(P

0.
03
)
th
an
th
e
va
lu
e
fo
r
co
nt
ro
la
ni
m
al
s.
c
T
hi
s
va
lu
e
w
as
si
gn
ifi
ca
nt
ly
lo
w
er
(P

0.
04
)
th
an
th
e
va
lu
e
fo
r
co
nt
ro
la
ni
m
al
s.
3010 FANNING ET AL. ANTIMICROB. AGENTS CHEMOTHER.
 o
n
 N
ovem
ber 4, 2015 by University of Queensland Library
http://aac.asm
.org/
D
ow
nloaded from
 
10. Gloor, B., et al. 2003. Cefepime tissue penetration in experimental acute
pancreatitis. Pancreas 26:117–121.
11. Hung, D. Y., et al. 2002. Cationic drug pharmacokinetics in diseased livers
determined by fibrosis index, hepatic protein content, microsomal activity,
and nature of drug. J. Pharmacol. Exp. Ther. 301:1079–1087.
12. Hung, D. Y., P. Chang, K. Cheung, C. Winterford, and M. S. Roberts. 2002.
Quantitative evaluation of altered hepatic spaces and membrane transport in
fibrotic rat liver. Hepatology 36:1180–1189.
13. Isenmann, R., H. Friess, P. Schlegel, K. Fleischer, and M. W. Buchler. 1994.
Penetration of ciprofloxacin into the human pancreas. Infection 22:343–346.
14. Isenmann, R., et al. 2004. Prophylactic antibiotic treatment in patients with
predicted severe acute pancreatitis: a placebo-controlled, double-blind trial.
Gastroenterology 126:997–1004.
15. Lankisch, P. G., and M. M. Lerch. 2006. The role of antibiotic prophy-
laxis in the treatment of acute pancreatitis. J. Clin. Gastroenterol. 40:
149–155.
16. Merkord, J., L. Jonas, and G. Henninghausen. 1991. Morphological lesions
of pancreas and bile ducts in rats induced by dibutylin dichloride. Arch.
Toxicol. 14:75–79.
17. Saglamkaya, U., et al. 2002. Penetration of meropenem and cefepim into
pancreatic tissue during the course of experimental acute pancreatitis. Pan-
creas 24:264–268.
18. Schrader, H., et al. 2009. Reduced pancreatic volume and beta-cell area in
patients with chronic pancreatitis. Gastroenterology 136:513–522.
19. Spicak, J., J. Martinek, F. Zavada, J. Moravek, and V. Melenovsky. 1999.
Penetration of antibiotics into the pancreas in rats: an effect of acute necro-
tizing pancreatitis. Scand. J. Gastroenterol. 34:92–97.
20. Trudel, J. L., C. Wittnich, and R. A. Brown. 1994. Antibiotics bioavailability
in acute experimental pancreatitis. J. Am. Coll. Surg. 178:475–479.
21. Volpe, D. A. 2004. Permeability classification of representative fluoroquino-
lones by a cell culture method. AAPS J. 6(2):1–6.
VOL. 55, 2011 CHANGES IN ANTIBIOTIC DISTRIBUTION DUE TO PANCREATITIS 3011
 o
n
 N
ovem
ber 4, 2015 by University of Queensland Library
http://aac.asm
.org/
D
ow
nloaded from
 
